Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Maguire

Showing results (501-510 of 594) with videos related to

Pageof 60
Sort By:
The Journal of Pathology|October 30, 2020
miRNA-200c-3p promotes endothelial to mesenchymal transition and neointimal hyperplasia in artery bypass graftsDan Chen, Cheng Zhang, Jiangyong Chen, et al.
Chemmedchem|May 1, 2012
Pentacycloundecane-diol-based HIV-1 protease inhibitors: biological screening, 2D NMR, and molecular simulation studiesBahareh Honarparvar, Maya M Makatini, Sachin A Pawar, et al.
Clinical Ophthalmology (Auckland, N.Z.)|March 10, 2021
A Virtual Reality Orientation and Mobility Test for Inherited Retinal Degenerations: Testing a Proof-of-Concept After Gene TherapyTomas S Aleman, Alexander J Miller, Katherine H Maguire, et al.
Oncology Reports|June 10, 2005
Measurement of plasminogen activator system components in plasma and tumor tissue extracts obtained from patients with breast cancer: an EORTC Receptor and Biomarker Group collaborationN Grebenchtchikov, T M Maguire, R Riisbro, et al.
Ophthalmology|April 2, 2021
Durability of Voretigene Neparvovec for Biallelic RPE65-Mediated Inherited Retinal Disease: Phase 3 Results at 3 and 4 YearsAlbert M Maguire, Stephen Russell, Daniel C Chung, et al.
JAMA Ophthalmology|October 4, 2019
Utility of In Vitro Mutagenesis of RPE65 Protein for Verification of Mutational Pathogenicity Before Gene TherapyUnikora Yang, Susan Gentleman, Xiaowu Gai, et al.
Seminars in Oncology|June 1, 1987
Intensive postremission therapy in adults with acute nonlymphocytic leukemia using various dose schedules of ara-C: a progress report from the CALGB. Cancer and Leukemia Group BR J Mayer, C A Schiffer, B A Peterson, et al.
The Journal of Clinical Investigation|May 25, 2011
The human visual cortex responds to gene therapy-mediated recovery of retinal functionManzar Ashtari, Laura L Cyckowski, Justin F Monroe, et al.
Seminars in Oncology|June 1, 1985
Intensive postremission therapy in adults with acute nonlymphocytic leukemia with ara-C by continuous infusion or bolus administration: preliminary results of a CALGB phase I studyR J Mayer, C A Schiffer, B A Peterson, et al.
MDM Policy & Practice|September 23, 2021
Risk Communication After Health Care Exposures: An Experimental Vignette Survey With PatientsA Rani Elwy, Elizabeth M Maguire, Thomas H Gallagher, et al.
Pageof 60

Showing results (501-510 of 594) with videos related to

Sort By:
Pageof 60
The Journal of Pathology|October 30, 2020
miRNA-200c-3p promotes endothelial to mesenchymal transition and neointimal hyperplasia in artery bypass graftsDan Chen, Cheng Zhang, Jiangyong Chen, et al.
Chemmedchem|May 1, 2012
Pentacycloundecane-diol-based HIV-1 protease inhibitors: biological screening, 2D NMR, and molecular simulation studiesBahareh Honarparvar, Maya M Makatini, Sachin A Pawar, et al.
Clinical Ophthalmology (Auckland, N.Z.)|March 10, 2021
A Virtual Reality Orientation and Mobility Test for Inherited Retinal Degenerations: Testing a Proof-of-Concept After Gene TherapyTomas S Aleman, Alexander J Miller, Katherine H Maguire, et al.
Oncology Reports|June 10, 2005
Measurement of plasminogen activator system components in plasma and tumor tissue extracts obtained from patients with breast cancer: an EORTC Receptor and Biomarker Group collaborationN Grebenchtchikov, T M Maguire, R Riisbro, et al.
Ophthalmology|April 2, 2021
Durability of Voretigene Neparvovec for Biallelic RPE65-Mediated Inherited Retinal Disease: Phase 3 Results at 3 and 4 YearsAlbert M Maguire, Stephen Russell, Daniel C Chung, et al.
JAMA Ophthalmology|October 4, 2019
Utility of In Vitro Mutagenesis of RPE65 Protein for Verification of Mutational Pathogenicity Before Gene TherapyUnikora Yang, Susan Gentleman, Xiaowu Gai, et al.
Seminars in Oncology|June 1, 1987
Intensive postremission therapy in adults with acute nonlymphocytic leukemia using various dose schedules of ara-C: a progress report from the CALGB. Cancer and Leukemia Group BR J Mayer, C A Schiffer, B A Peterson, et al.
The Journal of Clinical Investigation|May 25, 2011
The human visual cortex responds to gene therapy-mediated recovery of retinal functionManzar Ashtari, Laura L Cyckowski, Justin F Monroe, et al.
Seminars in Oncology|June 1, 1985
Intensive postremission therapy in adults with acute nonlymphocytic leukemia with ara-C by continuous infusion or bolus administration: preliminary results of a CALGB phase I studyR J Mayer, C A Schiffer, B A Peterson, et al.
MDM Policy & Practice|September 23, 2021
Risk Communication After Health Care Exposures: An Experimental Vignette Survey With PatientsA Rani Elwy, Elizabeth M Maguire, Thomas H Gallagher, et al.
Pageof 60